Abstract
Erectile dysfunction is a common complication of spinal cord injury. Of the 68 spinal cord injured men in whom treatment with papaverine was initiated a therapeutic dosage was determined in 50 (74%). Papaverine was injected into the base of one corpora cavernosum. The dose started at 3 mg and was increased at weekly or longer intervals until an effective dose was determined. There were 15 (30%) men with tetraplegia and 35 (70%) men with paraplegia. The dosage of papaverine did not relate to the level or extent of injury. Doses of 12 mg or less were used in 56% of patients. Low dose papaverine is a safe and effective means of restoring erections in spinal cord injured men.
Similar content being viewed by others
Article PDF
References
Brindley G S . Pilot experiments on the action of drugs injected into the human corpas cavernosum penis. Br J Pharmacol 1986; 87: 495–500.
Lue T F, Tanagho E A . Physiology of erection and pharmacological management of impotence. J Urol 1987; 137: 829–836.
Virag R et al. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8 year experience with 615 cases. J Urol 1991; 145: 287–293.
Lee M, Sharifi R . Information and treatment with intracavernous injections of papaverine and phentolamine. Letter to the Editor. J Urol 1987; 137: 1008–1010.
Wyndaele J J, deMeyer J M, deSy W A, Claesseus H . Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury. Paraplegia 1986; 24: 271–275.
Sidi A A, Cameron J S, Duffy L M, Lanje P H . Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. J Urol 1986; 135: 704–706.
Lloyd L, Richards J S . Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury. Paraplegia 1989; 27: 457–464.
Siosteen A et al. Sexual ability, activity, attitudes and satisfaction as part of adjustment in spinal cord injured subjects. Paraplegia 1990; 28: 285–295.
Hu K N, Burks C, Christy W C . Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection. J Urol 1987; 138: 404–405.
Virag R . Intracavernous injection of papaverine for erectile failure. Letter to the Editor. Lancet 1982; 2: 938.
Earle C M et al. Prostaglandin E1 therapy for impotence, comparison with papaverine. J Urol 1990: 143: 57–59.
Floth A, Schramek P . Intracavernous injection of prostaglandin El in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin El alone. J Urol 1991; 145: 56–59.
Juenemann K P, Lue T F, Fournier Jr G R, Tanagho E A . Hemodynamics of papaverine and phentolamine-induced penile erection. J Urol 1986; 136: 158–161.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yarkony, G., Chen, D., Palmer, J. et al. Management of impotence due to spinal cord injury using low dose papaverine. Spinal Cord 33, 77–79 (1995). https://doi.org/10.1038/sc.1995.19
Issue Date:
DOI: https://doi.org/10.1038/sc.1995.19